Since chemotherapy is one of the major treatments for NSCLC patients in a setting of almost certain eventual chemoresistance, we next investigated whether SET overexpression affects the sensitivity of lung cancer cells to chemotherapy. The gene discussed is SET; the disease is lung carcinoma.